Filters close
Released: 16-Nov-2014 4:45 PM EST
Blood Clot and Heart Attack Risk After Coronary Stent Treatment Reduced with Continuation of Dual Antiplatelet Therapy Beyond One Year in DAPT Study Findings
Harvard Clinical Research Institute

Results from the DAPT Study were announced in November in multiple presentations at the American Heart Association Scientific Sessions 2014. Results from the primary study analysis were concurrently published in The New England Journal of Medicine, and an investigator-led meta-analysis was published in The Lancet.

26-Jun-2014 9:00 AM EDT
American Journal of Managed Care Publishes Results Showing Big Data Analytics Can Predict Individualized Risk of Metabolic Syndrome in Patients
GNS Healthcare

GNS Healthcare (big data analytics company) and Aetna (the fifth-largest health care insurance provider) announce published research findings from a study analyzing 37,000 patient health care records that predict and revealed specific personalized health care interventions for metabolic syndrome.

Released: 22-Apr-2014 9:00 AM EDT
Neurophage Discovers GAIM-Changing Molecules to Combat Alzheimer’s Disease and Other Neurodegenerative Disorders
MacDougall Biomedical Communications

Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer’s, Parkinson’s and Huntington’s diseases.

Released: 9-Jan-2014 12:30 PM EST
T2 Biosystems and Collaborators Announce Discovery of Novel Clot Structure Biology Enabled by T2HemoStat
MacDougall Biomedical Communications

T2 Bio and collaborators published data in Blood describing novel clot structure biology detected while testing T2 Bio’s T2HemoStat™ that could help identify stroke and heart attack victims who are less responsive to medications.


Showing results 1 – 4 of 4


close
0.08003